Novelix Pharmaceuticals Ltd — Important, 30-05-2026: Company Update

Novelix Pharmaceuticals has allotted 28.10 lakh new equity shares, each with a face value of Rs. 10 and an issue price of Rs. 20 (including Rs. 10 premium). This allotment resulted from existing warrant holders, including promoters, exercising their option to convert warrants into shares. The company received Rs. 4.215 Cr from this conversion. Consequently, the paid-up equity capital increased from Rs. 21.085 Cr to Rs. 23.895 Cr. This move strengthens the company's capital base and reflects continued commitment from investors.